Gilead Sciences (GILD) Misses Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $150.56 +0.30%
Revenue Growth %: -0.4%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: -0.4%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $3.03, $0.10 worse than the analyst estimate of $3.13. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $8.08 billion. Gilead Sciences reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
- Microchip Technology completes acquisition of Hailo
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
